<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39380728</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Quantitative real time PCR for distinction between <i>Pneumocystis jirovecii</i> infection/colonization in hospitalized patients.</ArticleTitle><Pagination><StartPage>1426200</StartPage><MedlinePgn>1426200</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1426200</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2024.1426200</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Identification of the opportunistic fungus <i>Pneumocystis jirovecii</i> in respiratory specimens presents challenges, particularly in differentiating between colonization and active infection. The present study assessed a probe-based real time PCR (qPCR) diagnostic effectiveness in patients with diverse underlying conditions, particularly those with COVID-19 and pulmonary insufficiency.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">To set up the qPCR, clinical samples from 281 patients with respiratory ailments were tested. Subsequently, a descriptive study was conducted on 112 patients with pulmonary insufficiency with and without COVID-19 suspected of <i>P. jirovecii</i> infection. All specimens were subjected to DNA extraction followed by nested PCR and qPCR targeting the mitochondrial large subunit (mtLSU)-rRNA gene.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Based on nested PCR and qPCR, <i>P. jirovecii</i> was identified in 40 out of 281 patients, with slight variations in positive samples observed across dilutions. Three patients who tested positive in nested PCR yielded negative results in probe-based qPCR. Conversely, three patients who tested positive in probe-based qPCR yielded negative results in nested PCR. Considering nested PCR as the golden standard, probe-based qPCR demonstrated good diagnostic performance, with 92.5% sensitivity and 98.7% specificity. Based on cycle threshold (Ct) values, the positive cases were categorized: ≤32 as infection, &gt;35 as colonization, and a grey zone between these values (32 &lt; X ≤ 35). The analysis of 112 PCP-suspected patients revealed a prevalence ranging from 6.25% (nested PCR) to 7% (probe-based qPCR).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">This study suggested Ct values to differentiate <i>Pneumocystis</i> pneumonia/colonization in immunocompromised patients. To further augment the diagnostic sensitivity, it is recommended to integrate qPCR results with clinical parameters and biomarkers to offer a more precise understanding of <i>Pneumocystis</i>-related conditions.</AbstractText><CopyrightInformation>Copyright © 2024 Rouhi, Erami, Rastgufar, Jahani, Aboutalebian, Soltani, Fakhim and Mirhendi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rouhi</LastName><ForeName>Faezeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erami</LastName><ForeName>Mahzad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, School of Medicine, Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rastgufar</LastName><ForeName>Sepide</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology and Histology, School of Medicine, Shahid Beheshti Hospital, Kashan University of Medical Sciences, Kashan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jahani</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, School of Medicine, Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aboutalebian</LastName><ForeName>Shima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mycology Reference Laboratory, Research Core Facilities Laboratory, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soltani</LastName><ForeName>Sajedeh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fakhim</LastName><ForeName>Hamed</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirhendi</LastName><ForeName>Hossein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Mycology Reference Laboratory, Research Core Facilities Laboratory, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004271">DNA, Fungal</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045363" MajorTopicYN="Y">Pneumocystis carinii</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="Y">Real-Time Polymerase Chain Reaction</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011020" MajorTopicYN="Y">Pneumonia, Pneumocystis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="Y">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004271" MajorTopicYN="N">DNA, Fungal</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Iran</Keyword><Keyword MajorTopicYN="N">Pneumocystis jirovecii</Keyword><Keyword MajorTopicYN="N">diagnosis</Keyword><Keyword MajorTopicYN="N">nested PCR</Keyword><Keyword MajorTopicYN="N">qPCR</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>4</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39380728</ArticleId><ArticleId IdType="pmc">PMC11458531</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2024.1426200</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alanio A., Dellière S., Voicu S., Bretagne S., Mégarbane B. (2021). The presence of Pneumocystis jirovecii in critically ill patients with COVID-19. J. Infect. 82, 84–123. doi: 10.1016/j.jinf.2020.10.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.10.034</ArticleId><ArticleId IdType="pmc">PMC7609246</ArticleId><ArticleId IdType="pubmed">33157150</ArticleId></ArticleIdList></Reference><Reference><Citation>Alanio A., Desoubeaux G., Sarfati C., Hamane S., Bergeron A., Azoulay E., et al. . (2011). Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin. Microbiol. Infect. 17, 1531–1537. doi: 10.1111/j.1469-0691.2010.03400.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2010.03400.x</ArticleId><ArticleId IdType="pubmed">20946413</ArticleId></ArticleIdList></Reference><Reference><Citation>Albulushi K., Jung-Hynes B., Chen D. (2021). Detection of pneumocystis jirovecii from clinical specimens utilizing a taqMan-based real-time PCR assay on the luminex ARIES. Curr. Protoc. 1, e95. doi: 10.1002/cpz1.v1.4</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpz1.v1.4</ArticleId><ArticleId IdType="pubmed">33818923</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshahrani M. Y., Alfaifi M., Ahmad I., Alkhathami A. G., Hakami A. R., Ahmad H., et al. . (2020). Pneumocystis Jirovecii detection and comparison of multiple diagnostic methods with quantitative real-time PCR in patients with respiratory symptoms. Saudi J. Biol. Sci. 27, 1423–1427. doi: 10.1016/j.sjbs.2020.04.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjbs.2020.04.032</ArticleId><ArticleId IdType="pmc">PMC7254037</ArticleId><ArticleId IdType="pubmed">32489277</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcenas R. C., Uhl J. R., Buckwalter S. P., Limper A. H., Crino D., Roberts G. D., et al. . (2006). A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid. Diagn. Microbiol. Infect. Dis. 54, 169–175. doi: 10.1016/j.diagmicrobio.2005.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2005.08.006</ArticleId><ArticleId IdType="pubmed">16423488</ArticleId></ArticleIdList></Reference><Reference><Citation>Belanger C. R., Locher K., Velapatino B., Dufresne P. J., Eckbo E., Charles M. (2023). Quick versus Quantitative: Evaluation of Two Commercial Real-Time PCR Assays for the Detection of Pneumocystis jirovecii from Bronchoalveolar Lavage Fluids. Microbiol. Spectr. 11 (4), e01023. doi: 10.1128/spectrum.01021-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01021-23</ArticleId><ArticleId IdType="pmc">PMC10434167</ArticleId><ArticleId IdType="pubmed">37260378</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaize M., Mayaux J., Luyt C.-E., Lampros A., Fekkar A. (2020). COVID-19–related respiratory failure and lymphopenia do not seem associated with pneumocystosis. Am. J. Respir. Crit. Care Med. 202, 1734–1736. doi: 10.1164/rccm.202007-2938LE</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202007-2938LE</ArticleId><ArticleId IdType="pmc">PMC7737598</ArticleId><ArticleId IdType="pubmed">32941062</ArticleId></ArticleIdList></Reference><Reference><Citation>Botterel F., Cabaret O., Foulet F., Cordonnier C., Costa J.-M., Bretagne S. (2012). Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients. J. Clin. Microbiol. 50, 227–231. doi: 10.1128/JCM.06036-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.06036-11</ArticleId><ArticleId IdType="pmc">PMC3264196</ArticleId><ArticleId IdType="pubmed">22162560</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly J. P., Chen S. C., Kauffman C. A., Steinbach W. J., Baddley J. W., Verweij P. E., et al. . (2020). Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin. Infect. Dis. 71, 1367–1376. doi: 10.1093/cid/ciz1008</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciz1008</ArticleId><ArticleId IdType="pmc">PMC7486838</ArticleId><ArticleId IdType="pubmed">31802125</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauchier T., Hasseine L., Gari-Toussaint M., Casanova V., Marty P., Pomares C. (2016). Detection of Pneumocystis jirovecii by quantitative PCR to differentiate colonization and pneumonia in immunocompromised HIV-positive and HIV-negative patients. J. Clin. Microbiol. 54, 1487–1495. doi: 10.1128/JCM.03174-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.03174-15</ArticleId><ArticleId IdType="pmc">PMC4879311</ArticleId><ArticleId IdType="pubmed">27008872</ArticleId></ArticleIdList></Reference><Reference><Citation>Fillâtre P., Decaux O., Jouneau S., Revest M., Gacouin A., Robert-Gangneux F., et al. . (2014). Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients. Am. J. Med. 127, 1242.e11–. e17. doi: 10.1016/j.amjmed.2014.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2014.07.010</ArticleId><ArticleId IdType="pubmed">25058862</ArticleId></ArticleIdList></Reference><Reference><Citation>Flori P., Bellete B., Durand F., Raberin H., Cazorla C., Hafid J., et al. . (2004). Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. J. Med. Microbiol. 53, 603–607. doi: 10.1099/jmm.0.45528-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.45528-0</ArticleId><ArticleId IdType="pubmed">15184529</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T., Iwamoto A., Nakamura T. (2007). Pneumocystis pneumonia in patients with HIV infection: clinical manifestations, laboratory findings, and radiological features. J. Infect. Chemother. 13, 1–7. doi: 10.1007/s10156-006-0484-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10156-006-0484-5</ArticleId><ArticleId IdType="pubmed">17334722</ArticleId></ArticleIdList></Reference><Reference><Citation>Guegan H., Robert-Gangneux F. (2019). Molecular diagnosis of Pneumocystis pneumonia in immunocompromised patients. Curr. Opin. Infect. Dis. 32, 314–321. doi: 10.1097/QCO.0000000000000559</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000559</ArticleId><ArticleId IdType="pubmed">31107250</ArticleId></ArticleIdList></Reference><Reference><Citation>Huggett J. F., Taylor M. S., Kocjan G., Evans H. E., Morris-Jones S., Gant V., et al. . (2008). Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients. Thorax. 63, 154–159. doi: 10.1136/thx.2007.081687</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2007.081687</ArticleId><ArticleId IdType="pubmed">17693588</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly S., Waters L., Cevik M., Collins S., Lewis J., Wu M.-S., et al. . (2020). Pneumocystis pneumonia, a COVID-19 mimic, reminds us of the importance of HIV testing in COVID-19. Clin. Med. 20, 590. doi: 10.7861/clinmed.2020-0565</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0565</ArticleId><ArticleId IdType="pmc">PMC7687333</ArticleId><ArticleId IdType="pubmed">33199326</ArticleId></ArticleIdList></Reference><Reference><Citation>Linssen C. F., Jacobs J. A., Beckers P., Templeton K. E., Bakkers J., Kuijper E. J., et al. . (2006). Inter-laboratory comparison of three different real-time PCR assays for the detection of Pneumocystis jiroveci in bronchoalveolar lavage fluid samples. J. Med. Microbiol. 55, 1229–1235. doi: 10.1099/jmm.0.46552-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.46552-0</ArticleId><ArticleId IdType="pubmed">16914653</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L., Cissé O. H., Kovacs J. A. (2018). A molecular window into the biology and epidemiology of Pneumocystis spp. Clin. Microbiol. Rev. 31, e00009–e00018. doi: 10.1128/CMR.00009-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00009-18</ArticleId><ArticleId IdType="pmc">PMC6056843</ArticleId><ArticleId IdType="pubmed">29899010</ArticleId></ArticleIdList></Reference><Reference><Citation>Matouri R., Aboutalebian S., Nasri E., Sadeghi S., Rostami S., Fakhim H., et al. . (2023). Molecular and microscopy detection of Pneumocystis jirovecii in hospitalized patients during the COVID-19 pandemic. Front. Med. 10, 666. doi: 10.3389/fmed.2023.1148320</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1148320</ArticleId><ArticleId IdType="pmc">PMC10117983</ArticleId><ArticleId IdType="pubmed">37089605</ArticleId></ArticleIdList></Reference><Reference><Citation>Medrano F. J., Montes-Cano M., Conde M., de la Horra C., Respaldiza N., Gasch A., et al. . (2005). Pneumocystis jirovecii in general population. Emerg. Infect. Dis. 11, 245. doi: 10.3201/eid1102.040487</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1102.040487</ArticleId><ArticleId IdType="pmc">PMC3320436</ArticleId><ArticleId IdType="pubmed">15752442</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris A., Norris K. A. (2012). Colonization by Pneumocystis jirovecii and its role in disease. Clin. Microbiol. Rev. 25, 297–317. doi: 10.1128/CMR.00013-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00013-12</ArticleId><ArticleId IdType="pmc">PMC3346301</ArticleId><ArticleId IdType="pubmed">22491773</ArticleId></ArticleIdList></Reference><Reference><Citation>Perret T., Kritikos A., Hauser P. M., Guiver M., Coste A. T., Jaton K., et al. . (2020). Ability of quantitative PCR to discriminate Pneumocystis jirovecii pneumonia from colonization. J. Med. Microbiol. 69, 705. doi: 10.1099/jmm.0.001190</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.001190</ArticleId><ArticleId IdType="pmc">PMC7451042</ArticleId><ArticleId IdType="pubmed">32369002</ArticleId></ArticleIdList></Reference><Reference><Citation>Procop G., Haddad S., Quinn J., Wilson M., Henshaw N., Reller L., et al. . (2004). Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods. J. Clin. Microbiol. 42, 3333–3335. doi: 10.1128/JCM.42.7.3333-3335.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.42.7.3333-3335.2004</ArticleId><ArticleId IdType="pmc">PMC446244</ArticleId><ArticleId IdType="pubmed">15243109</ArticleId></ArticleIdList></Reference><Reference><Citation>Razazi K., Arrestier R., Haudebourg A. F., Botterel F., Mekontso Dessap A. (2021). Pneumocystis pneumonia risk among viral acute respiratory distress syndrome related or not to COVID 19. Crit. Care 25, 1–4. doi: 10.1186/s13054-021-03767-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03767-3</ArticleId><ArticleId IdType="pmc">PMC8474854</ArticleId><ArticleId IdType="pubmed">34565429</ArticleId></ArticleIdList></Reference><Reference><Citation>Robert-Gangneux F., Belaz S., Revest M., Tattevin P., Jouneau S., Decaux O., et al. . (2014). Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study. J. Clin. Microbiol. 52, 3370–3376. doi: 10.1128/JCM.01480-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01480-14</ArticleId><ArticleId IdType="pmc">PMC4313164</ArticleId><ArticleId IdType="pubmed">25009050</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogina P., Skvarc A. P. M. (2020). Diagnostic accuracy of (1→ 3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients. Radiol. Oncol. 54, 221. doi: 10.2478/raon-2020-0028</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/raon-2020-0028</ArticleId><ArticleId IdType="pmc">PMC7276650</ArticleId><ArticleId IdType="pubmed">32463392</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela J. M., Respaldiza N., Sánchez B., de la Horra C., Montes-Cano M., Rincón M., et al. . (2003). Lymphocyte response in subjects with chronic pulmonary disease colonized by Pneumocystis jirovecii. J. eukaryotic Microbiol. 50, 672–673. doi: 10.1111/j.1550-7408.2003.tb00680.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1550-7408.2003.tb00680.x</ArticleId><ArticleId IdType="pubmed">14736213</ArticleId></ArticleIdList></Reference><Reference><Citation>White P. L. (2021). Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls. Curr. Opin. Infect. Dis. 34, 573. doi: 10.1097/QCO.0000000000000791</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000791</ArticleId><ArticleId IdType="pmc">PMC8577304</ArticleId><ArticleId IdType="pubmed">34751180</ArticleId></ArticleIdList></Reference><Reference><Citation>White P. L., Price J. S., Backx M. (2019). Pneumocystis jirovecii pneumonia: epidemiology, clinical manifestation and diagnosis. Curr. Fungal Infect. Rep. 13, 260–273. doi: 10.1007/s12281-019-00349-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12281-019-00349-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S.-L., Wen Y.-H., Wu Y.-S., Wang M.-C., Chang P.-Y., Yang S., et al. . (2020). Diagnosis of Pneumocystis pneumonia by real-time PCR in patients with various underlying diseases. J. Microbiol. Immunol. Infect. 53, 785–790. doi: 10.1016/j.jmii.2019.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2019.08.012</ArticleId><ArticleId IdType="pubmed">31635929</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>